Health News Roundup: Swine fever and risks to food market in China; blockbuster drug Xarelto and more

Following is a summary of current health news briefs.

Swine fever in China among risks to food markets - FAO/OECD

The spread of a deadly pig disease in China that has disrupted the world's biggest pork market is one of the major risks to a well-supplied global agricultural sector, the FAO and OECD said on Monday. African swine fever was highlighted in the FAO and OECD's annual agricultural outlook for 2019-2028, which forecast broadly stable agricultural markets in the coming decade as productivity gains help output to keep pace with rising demand for food, livestock feed and crop-based biofuels.

Bayer seeks approval to treat children with blockbuster drug Xarelto

Bayer will apply for approval to make its blockbuster blood thinner Xarelto available for treating children, the German company said on Monday, after a study showed strong efficacy and safety in children with thromboembolism. The results of the phase III study were similar to those seen in previous studies with adults, the German company said in a statement.

Intra-Cellular drug fails one of two bipolar depression studies; shares fall

Intra-Cellular Therapies Inc said on Monday its lead drug failed to meet the main goal of one of two late-stage studies in patients with major depressive episodes associated with bipolar disorder. The company's shares fell 6.5% before the opening bell.

(With inputs from agencies.)